Related Experiment Video
Updated: Aug 1, 2026

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018
Quantitative structure-antitumor activity relationships of camptothecin analogues: cluster analysis and genetic
1Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Abstract:
Topoisomerase 1 (top1) inhibitors are proving useful against a range of refractory tumors, and there is considerable interest in the development of additional top1 agents. Despite crystallographic studies, the binding site and ligand properties that lead to activity are poorly understood. Here we report a unique approach to quantitative structure-activity relationship (QSAR) analysis based on the National Cancer Institute's (NCI) drug databases. In 1990, the NCI established a drug discovery program in which compounds are tested for their ability to inhibit the growth of 60 different human cancer cell lines in culture. More than 70 000 compounds have been screened, and patterns of activity against the 60 cell lines have been found to encode rich information on mechanisms of drug action and drug resistance. Here, we use hierarchical clustering to define antitumor activity patterns in a data set of 167 tested camptothecins (CPTs) in the NCI drug database. The average pairwise Pearson correlation coefficient between activity patterns for the CPT set was 0.70. Coherence between chemical structures and their activity patterns was observed. QSAR studies were carried out using the mean 50% growth inhibitory concentrations (GI(50)) for 60 cell lines as the dependent variables. Different statistical methods, including stepwise linear regression, principal component regression (PCR), partial least-squares regression (PLS), and fully cross-validated genetic function approximation (GFA) were applied to construct quantitative structure-antitumor relationship models. For our data set, the GFA method performed better in terms of correlation coefficients and cross-validation analysis. A number of molecular descriptors were identified as being correlated with antitumor activity. Included were partial atomic charges and three interatomic distances that define the relative spatial dispositions of three significant atoms (the hydroxyl hydrogen of the E-ring, the lactone carbonyl oxygen of the E-ring, and the carbonyl oxygen of the D-ring). The cross-validated r(2) for the final GFA model was 0.783, indicating a predictive QSAR model.
Insights
This study developed a quantitative structure-activity relationship (QSAR) model for topoisomerase 1 inhibitors using NCI drug data. The model identifies key molecular features correlating with antitumor activity, aiding in the design of novel cancer therapeutics.
Area of Science:
- Medicinal Chemistry
- Computational Biology
- Oncology
Background:
- Topoisomerase 1 (Top1) inhibitors are crucial for treating refractory tumors, yet their binding site and activity-driving ligand properties remain poorly understood.
- Developing new Top1 agents is of significant interest, necessitating a deeper understanding of structure-activity relationships.
Purpose of the Study:
- To establish a quantitative structure-activity relationship (QSAR) model for camptothecins (CPTs) using National Cancer Institute (NCI) drug databases.
- To identify molecular descriptors correlating with antitumor activity for improved drug design.
Main Methods:
- Utilized hierarchical clustering to analyze antitumor activity patterns of 167 CPTs from the NCI drug database.
- Applied various statistical methods, including genetic function approximation (GFA), to build QSAR models.
- Identified key molecular descriptors, including partial atomic charges and specific interatomic distances, correlated with antitumor activity.
Main Results:
- Observed coherence between CPT chemical structures and their antitumor activity patterns (average Pearson correlation coefficient of 0.70).
- The GFA method demonstrated superior performance in correlation and cross-validation compared to other statistical approaches.
- A predictive QSAR model was developed with a cross-validated r² of 0.783.
Conclusions:
- The developed QSAR model provides valuable insights into the structural determinants of Top1 inhibitor activity.
- This approach aids in understanding drug action and resistance mechanisms.
- The identified molecular descriptors can guide the rational design of novel and more effective Top1-based anticancer drugs.
More Related Videos
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020